Refractory/Recurrent Central Nervous System Lymphoma
1 clinical trials · Condition
◉ Watch Refractory/Recurrent Central Nervous System Lymphoma
| Record | Firm | Date |
|---|---|---|
| Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma (NCT06827782) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2025-03-01 |
Track Refractory/Recurrent Central Nervous System Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.